image
Technology - Software - Application - NASDAQ - US
$ 170.3332
-0.214 %
$ 20.4 B
Market Cap
46.1
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one PTC stock under the worst case scenario is HIDDEN Compared to the current market price of 170 USD, PTC Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one PTC stock under the base case scenario is HIDDEN Compared to the current market price of 170 USD, PTC Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one PTC stock under the best case scenario is HIDDEN Compared to the current market price of 170 USD, PTC Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart PTC

image
$210.0$210.0$200.0$200.0$190.0$190.0$180.0$180.0$170.0$170.0$160.0$160.0$150.0$150.0$140.0$140.0$130.0$130.015 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '25
FINANCIALS
2.3 B REVENUE
9.60%
588 M OPERATING INCOME
28.27%
376 M NET INCOME
53.27%
750 M OPERATING CASH FLOW
22.77%
-125 M INVESTING CASH FLOW
85.46%
-651 M FINANCING CASH FLOW
-249.60%
636 M REVENUE
12.61%
223 M OPERATING INCOME
93.44%
163 M NET INCOME
97.79%
281 M OPERATING CASH FLOW
17.98%
-18.9 M INVESTING CASH FLOW
-73.83%
-227 M FINANCING CASH FLOW
30.08%
Balance Sheet PTC Inc.
image
Current Assets 1.3 B
Cash & Short-Term Investments 266 M
Receivables 862 M
Other Current Assets 171 M
Non-Current Assets 5.08 B
Long-Term Investments 10 K
PP&E 209 M
Other Non-Current Assets 4.88 B
4.16 %13.50 %3.27 %76.39 %Total Assets$6.4b
Current Liabilities 1.67 B
Accounts Payable 24.2 M
Short-Term Debt 546 M
Other Current Liabilities 1.1 B
Non-Current Liabilities 1.5 B
Long-Term Debt 1.38 B
Other Non-Current Liabilities 117 M
17.22 %34.63 %43.69 %3.70 %Total Liabilities$3.2b
EFFICIENCY
Earnings Waterfall PTC Inc.
image
Revenue 2.3 B
Cost Of Revenue 445 M
Gross Profit 1.85 B
Operating Expenses 1.22 B
Operating Income 588 M
Other Expenses 212 M
Net Income 376 M
3b3b2b2b2b2b1b1b500m500m002b(445m)2b(1b)588m(212m)376mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
80.65% GROSS MARGIN
80.65%
25.58% OPERATING MARGIN
25.58%
16.37% NET MARGIN
16.37%
11.71% ROE
11.71%
5.90% ROA
5.90%
8.97% ROIC
8.97%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis PTC Inc.
image
800m800m700m700m600m600m500m500m400m400m300m300m200m200m100m100m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 376 M
Depreciation & Amortization 141 M
Capital Expenditures -14.4 M
Stock-Based Compensation 223 M
Change in Working Capital 49.4 M
Others 24.7 M
Free Cash Flow 736 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets PTC Inc.
image
Wall Street analysts predict an average 1-year price target for PTC of $201 , with forecasts ranging from a low of $175 to a high of $228 .
PTC Lowest Price Target Wall Street Target
175 USD 2.74%
PTC Average Price Target Wall Street Target
201 USD 17.78%
PTC Highest Price Target Wall Street Target
228 USD 33.86%
Price
Max Price Target
Min Price Target
Average Price Target
230230220220210210200200190190180180170170160160150150140140130130Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 10
6. Ownership
Insider Ownership PTC Inc.
image
Sold
0-3 MONTHS
324 K USD 2
3-6 MONTHS
323 K USD 2
6-9 MONTHS
5.6 M USD 4
9-12 MONTHS
3.22 M USD 5
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  or 646-581-9980, ext. 7980. globenewswire.com - 1 week ago
Why PTC Inc. (PTC) is a Top Value Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com - 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ:PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 2 weeks ago
3 Things Nvidia Management Just Said That Build the Buy Case for These 3 Magnificent Hidden AI Stocks Nvidia's (NVDA 0.51%) recent earnings report boosted the market and alleviated concerns about any slowdown in artificial intelligence (AI) and data-center-related spending. That's great news for Nvidia and other frontline players in the AI/data center industry. fool.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ:PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 2 weeks ago
PTC Launches Creo 12 to Accelerate Design Speed, Productivity, and Collaboration Productivity improvements help accelerate design workflows and collaboration Faster composite design and manufacturing while maintaining high precision and quality Advanced simulation and AI-driven generative design support earlier product optimization Significantly expanded cable harness design capabilities improve design processes for electrification initiatives BOSTON , June 4, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the latest version of its Creo® computer-aided design (CAD) solution, built to help manufacturers deliver their best designs in less time. Creo 12 introduces hundreds of powerful enhancements to its design, simulation, and manufacturing capabilities, enabling teams to work smarter, get more done, and collaborate more effectively. prnewswire.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK CITY, NY / ACCESS Newswire / June 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ:PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  or 646-581-9980, ext. 7980. globenewswire.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK , June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com - 2 weeks ago
Why Is PTC Inc. (PTC) Up 7.4% Since Last Earnings Report? PTC Inc. (PTC) reported earnings 30 days ago. What's next for the stock? zacks.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ:PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 3 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT NEW YORK , May 26, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com - 3 weeks ago
8. Profile Summary

PTC Inc. PTC

image
COUNTRY US
INDUSTRY Software - Application
MARKET CAP $ 20.4 B
Dividend Yield 0.00%
Description PTC Inc. operates as software and services company in the Americas, Europe, and the Asia Pacific. The company operates in two segments, Software Products and Professional Services. It offers ThingWorx platform, which offers a set of capabilities that enable enterprises to digitally transform every aspect of their business with innovative solutions that are simple to create, easy to implement, scalable to meet future needs, and designed to enable customers to accelerate time to value; and Vuforia, which enables the visualization of digital information in a physical context and the creation of AR. The company also provides Onshape, a software-as-a-service product development platform unites computer-aided design with data management, collaboration tools, and real-time analytics; Arena, a PLM solution enables product teams to collaborate virtually anytime and anywhere; Creo, a 3D CAD technology enables the digital design, testing, and modification of product models; and Windchill, a product lifecycle management software. In addition, it offers Integrity, an application lifecycle management solution; Servigistics, service parts management solution; and consulting, implementation, training, cloud, and license and support services. The company was formerly known as Parametric Technology Corporation and changed its name to PTC Inc. in January 2013. PTC Inc. was incorporated in 1985 and is headquartered in Boston, Massachusetts.
Contact 121 Seaport Boulevard, Boston, MA, 02210 https://www.ptc.com
IPO Date Dec. 8, 1989
Employees 7512
Officers Mr. Kristian P. Talvitie Executive Vice President & Chief Financial Officer Mr. Aaron C. Von Staats Esq. Executive Vice President, General Counsel & Corporate Secretary Ms. Lisa Reilly Executive Vice President & Chief People Officer Ms. Catherine A. Kniker EVice President, Chief Marketing & Sustainability Officer Ms. Alice Christenson Chief Accounting Officer Mr. Matthew Shimao Senior Vice President of Investor Relations Mr. Kevin P. Wrenn Chief Product Officer Catherine Gorecki Senior Vice President of Corporate & Securities Counsel and Assistant Secretary Mr. Eric Snow Senior Vice President of Corporate Marketing Mr. Neil Barua President, Chief Executive Officer & Director